Maynard Um
-
-
-
-
-
-
-
Iovance receives Health Canada approval for melanoma cell therapy
-
-
-
-
-
-
-
IOVA 3-DAY DEADLINE ALERT: Hagens Berman Reminds Iovance (IOVA) Investors of Pending Securities Class Action, Encourages Investors with Losses to Contact the Firm
-
-
-
-
-
-
-
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
-
-
-
-
-
-
-
IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Iovance Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
-
-
-
-
-
-
Scott+Scott Attorneys at Law LLP Alerts Investors of The Pending Class Action Against Iovance Biotherapeutics, Inc. (IOVA)
-
-
-
-
-
-
-
IOVA DEADLINE: BFA Law Reminds Iovance Biotherapeutics Investors with Losses to Submit their Information before July 14 Class Action Deadline
-
-
-
-
-
-
-
Scott+Scott Attorneys at Law LLP Reminds Investors Of The Class Action That Has Been Filed Against Iovance Biotherapeutics, Inc. (IOVA)
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

